Trigeminal neuralgia can occur at any age, but it is more common among those older than 50 years
Any soreness typically resolves within 24 hours
Liu H, Liu D, Zhao X, Wright M, Guo H, Deng Y, Guo H
However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
Regulatory and safety status: Ipamorelin is pending FDA review
A licensed medical provider can evaluate whether a peptide is appropriate for your goals